Moving on to clinical studies, we recently reported that DKD patients had reduced excretion of 20-HETE in urine in comparison with control subjects, suggesting an accumulation of this eicosanoid in tissues where CYP4F2 is highly expressed such as the kidney [13]. This evidence concerns the gene CYP4F2 and diabetic kidney disease.